Titre : Paludisme à Plasmodium vivax

Paludisme à Plasmodium vivax : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cell Cycle Checkpoints
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Paludisme à Plasmodium vivax : Questions médicales les plus fréquentes", "headline": "Paludisme à Plasmodium vivax : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Paludisme à Plasmodium vivax : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-05", "dateModified": "2025-02-28", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Paludisme à Plasmodium vivax" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Paludisme", "url": "https://questionsmedicales.fr/mesh/D008288", "about": { "@type": "MedicalCondition", "name": "Paludisme", "code": { "@type": "MedicalCode", "code": "D008288", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.920.875" } } }, "about": { "@type": "MedicalCondition", "name": "Paludisme à Plasmodium vivax", "alternateName": "Malaria, Vivax", "code": { "@type": "MedicalCode", "code": "D016780", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Nicholas M Anstey", "url": "https://questionsmedicales.fr/author/Nicholas%20M%20Anstey", "affiliation": { "@type": "Organization", "name": "Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia. Electronic address: nicholas.anstey@menzies.edu.au." } }, { "@type": "Person", "name": "Marcus V G Lacerda", "url": "https://questionsmedicales.fr/author/Marcus%20V%20G%20Lacerda", "affiliation": { "@type": "Organization", "name": "State University of Amazonas (UEA), Manaus, Amazonas, Brazil/Tropical Medicine Foundation-Dr. Heitor Vieira Dourado (FMT-HVD), Manaus, Amazonas, Brazil." } }, { "@type": "Person", "name": "Cindy S Chu", "url": "https://questionsmedicales.fr/author/Cindy%20S%20Chu", "affiliation": { "@type": "Organization", "name": "Shoklo Malaria Research Unit-Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand." } }, { "@type": "Person", "name": "Nicholas J White", "url": "https://questionsmedicales.fr/author/Nicholas%20J%20White", "affiliation": { "@type": "Organization", "name": "Shoklo Malaria Research Unit-Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand." } }, { "@type": "Person", "name": "Wuelton M Monteiro", "url": "https://questionsmedicales.fr/author/Wuelton%20M%20Monteiro", "affiliation": { "@type": "Organization", "name": "State University of Amazonas (UEA), Manaus, Amazonas, Brazil/Tropical Medicine Foundation-Dr. Heitor Vieira Dourado (FMT-HVD), Manaus, Amazonas, Brazil." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Association between endometrial thickness and birthweight of singletons from vitrified-warmed cycles: a retrospective cohort study.", "datePublished": "2023-11-26", "url": "https://questionsmedicales.fr/article/38772201", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.rbmo.2023.103736" } }, { "@type": "ScholarlyArticle", "name": "The Intransitive Logic of Directed Cycles and Flipons Enhances the Evolution of Molecular Computers by Augmenting the Kolmogorov Complexity of Genomes.", "datePublished": "2023-11-18", "url": "https://questionsmedicales.fr/article/38003672", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms242216482" } }, { "@type": "ScholarlyArticle", "name": "Pyrogenic Carbon Promotes Anaerobic Oxidation of Methane Coupled with Iron Reduction via the Redox-Cycling Mechanism.", "datePublished": "2023-11-10", "url": "https://questionsmedicales.fr/article/37947777", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.est.3c05907" } }, { "@type": "ScholarlyArticle", "name": "Severe Methotrexate Toxicity Following a Capizzi Cycle in an Obese Adolescent With Acute Lymphoblastic Leukemia and Hepatic Steatosis.", "datePublished": "2023-11-02", "url": "https://questionsmedicales.fr/article/37916829", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MPH.0000000000002771" } }, { "@type": "ScholarlyArticle", "name": "Guarana (Paullinia cupana) but Not Low-Dose Caffeine Improves Cycling Time-Trial Performance Versus Placebo.", "datePublished": "2023-10-28", "url": "https://questionsmedicales.fr/article/37898479", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1123/ijsnem.2023-0148" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Infection", "item": "https://questionsmedicales.fr/mesh/D007239" }, { "@type": "ListItem", "position": 3, "name": "Maladies vectorielles", "item": "https://questionsmedicales.fr/mesh/D000079426" }, { "@type": "ListItem", "position": 4, "name": "Paludisme", "item": "https://questionsmedicales.fr/mesh/D008288" }, { "@type": "ListItem", "position": 5, "name": "Paludisme à Plasmodium vivax", "item": "https://questionsmedicales.fr/mesh/D016780" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Paludisme à Plasmodium vivax - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Paludisme à Plasmodium vivax", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Paludisme à Plasmodium vivax", "description": "Comment diagnostique-t-on le paludisme à Plasmodium vivax ?\nQuels tests sont utilisés pour le paludisme ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on diagnostiquer le paludisme sans test sanguin ?\nLe diagnostic précoce est-il important ?", "url": "https://questionsmedicales.fr/mesh/D016780?mesh_terms=Cell+Cycle+Checkpoints&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Paludisme à Plasmodium vivax", "description": "Quels sont les symptômes du paludisme à Plasmodium vivax ?\nLa fièvre est-elle constante dans le paludisme ?\nY a-t-il des symptômes spécifiques à Plasmodium vivax ?\nLes symptômes apparaissent-ils rapidement ?\nPeut-on avoir des symptômes sans infection ?", "url": "https://questionsmedicales.fr/mesh/D016780?mesh_terms=Cell+Cycle+Checkpoints&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Paludisme à Plasmodium vivax", "description": "Comment prévenir le paludisme à Plasmodium vivax ?\nLes vaccins contre le paludisme existent-ils ?\nLes traitements préventifs sont-ils disponibles ?\nLes insecticides sont-ils efficaces contre les moustiques ?\nLes mesures d'hygiène aident-elles à prévenir le paludisme ?", "url": "https://questionsmedicales.fr/mesh/D016780?mesh_terms=Cell+Cycle+Checkpoints&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Paludisme à Plasmodium vivax", "description": "Quel est le traitement standard pour Plasmodium vivax ?\nLa résistance aux médicaments est-elle un problème ?\nCombien de temps dure le traitement ?\nLes traitements sont-ils différents pour les enfants ?\nY a-t-il des effets secondaires au traitement ?", "url": "https://questionsmedicales.fr/mesh/D016780?mesh_terms=Cell+Cycle+Checkpoints&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Paludisme à Plasmodium vivax", "description": "Quelles sont les complications possibles du paludisme ?\nLe paludisme peut-il être mortel ?\nComment l'anémie est-elle liée au paludisme ?\nLes complications sont-elles fréquentes ?\nLe paludisme peut-il affecter la grossesse ?", "url": "https://questionsmedicales.fr/mesh/D016780?mesh_terms=Cell+Cycle+Checkpoints&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Paludisme à Plasmodium vivax", "description": "Quels sont les principaux facteurs de risque du paludisme ?\nLes enfants sont-ils plus à risque ?\nLes voyageurs sont-ils à risque ?\nL'immunité affecte-t-elle le risque de paludisme ?\nLes personnes immunodéprimées sont-elles plus vulnérables ?", "url": "https://questionsmedicales.fr/mesh/D016780?mesh_terms=Cell+Cycle+Checkpoints&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on le paludisme à Plasmodium vivax ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par un test sanguin pour détecter le parasite ou ses antigènes." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le paludisme ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de goutte épaisse et de frottis sanguin sont couramment utilisés." } }, { "@type": "Question", "name": "Les symptômes aident-ils au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes comme la fièvre et les frissons orientent vers un diagnostic de paludisme." } }, { "@type": "Question", "name": "Peut-on diagnostiquer le paludisme sans test sanguin ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, un test sanguin est essentiel pour confirmer la présence du parasite." } }, { "@type": "Question", "name": "Le diagnostic précoce est-il important ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un diagnostic précoce permet un traitement rapide et réduit les complications." } }, { "@type": "Question", "name": "Quels sont les symptômes du paludisme à Plasmodium vivax ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, frissons, maux de tête et fatigue intense." } }, { "@type": "Question", "name": "La fièvre est-elle constante dans le paludisme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, la fièvre peut être intermittente, avec des pics tous les deux jours." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques à Plasmodium vivax ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme l'anémie et la splénomégalie peuvent être plus fréquents." } }, { "@type": "Question", "name": "Les symptômes apparaissent-ils rapidement ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Ils apparaissent généralement 10 à 14 jours après la piqûre du moustique infecté." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans infection ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Non, les symptômes sont généralement liés à une infection active par le parasite." } }, { "@type": "Question", "name": "Comment prévenir le paludisme à Plasmodium vivax ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "L'utilisation de moustiquaires imprégnées et de répulsifs est essentielle." } }, { "@type": "Question", "name": "Les vaccins contre le paludisme existent-ils ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccin spécifique pour Plasmodium vivax." } }, { "@type": "Question", "name": "Les traitements préventifs sont-ils disponibles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements préventifs peuvent être administrés aux voyageurs dans les zones à risque." } }, { "@type": "Question", "name": "Les insecticides sont-ils efficaces contre les moustiques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'utilisation d'insecticides peut réduire la population de moustiques porteurs." } }, { "@type": "Question", "name": "Les mesures d'hygiène aident-elles à prévenir le paludisme ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, maintenir un environnement propre et sans eau stagnante réduit les risques." } }, { "@type": "Question", "name": "Quel est le traitement standard pour Plasmodium vivax ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement standard inclut la chloroquine suivie de la primaquine pour prévenir les rechutes." } }, { "@type": "Question", "name": "La résistance aux médicaments est-elle un problème ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des cas de résistance à la chloroquine ont été signalés dans certaines régions." } }, { "@type": "Question", "name": "Combien de temps dure le traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement par chloroquine dure généralement 3 jours, suivi de 14 jours de primaquine." } }, { "@type": "Question", "name": "Les traitements sont-ils différents pour les enfants ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les doses sont ajustées en fonction du poids et de l'âge de l'enfant." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires au traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des effets secondaires comme des nausées et des maux de tête peuvent survenir." } }, { "@type": "Question", "name": "Quelles sont les complications possibles du paludisme ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'anémie sévère, l'insuffisance rénale et le coma." } }, { "@type": "Question", "name": "Le paludisme peut-il être mortel ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sans traitement approprié, le paludisme peut entraîner la mort." } }, { "@type": "Question", "name": "Comment l'anémie est-elle liée au paludisme ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "L'anémie résulte de la destruction des globules rouges par le parasite." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont plus fréquentes chez les personnes non traitées ou immunodéprimées." } }, { "@type": "Question", "name": "Le paludisme peut-il affecter la grossesse ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut entraîner des complications graves pour la mère et le fœtus." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque du paludisme ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent vivre dans une zone endémique et ne pas utiliser de protection." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants ont un risque accru de développer des formes sévères de paludisme." } }, { "@type": "Question", "name": "Les voyageurs sont-ils à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyageurs vers des zones endémiques doivent prendre des précautions." } }, { "@type": "Question", "name": "L'immunité affecte-t-elle le risque de paludisme ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes ayant déjà été infectées peuvent avoir une immunité partielle." } }, { "@type": "Question", "name": "Les personnes immunodéprimées sont-elles plus vulnérables ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles courent un risque accru de complications graves liées au paludisme." } } ] } ] }

Sources (10000 au total)

Association between endometrial thickness and birthweight of singletons from vitrified-warmed cycles: a retrospective cohort study.

What is the association between endometrial thickness (EMT) and the birthweight of singleton infants born from frozen-thawed embryo transfer cycles?... This retrospective cohort study was conducted from January 2016 to December 2019. Participants were categorized into a natural cycle (NC, n = 8132) group and hormone replacement therapy (HRT, n = 4975... In the HRT group, the risk of delivering a small for gestational age (SGA) infant was increased in women with an EMT <8.0 mm (adjusted odds ratio [aOR] 1.85, 95% confidence interval [CI] 1.17-2.91) co... A thinner endometrium seen in women undergoing HRT cycles was associated with a lower birthweight z-score, as well as a higher risk of SGA. However, no significant association was observed between EMT...

Expression of apelin and apelin receptor protein in the hypothalamo-pituitary-ovarian axis during estrous cycle of mice.

Apelin is an endogenous neuropeptide expressed in the hypothalamus, pituitary and ovary; binds to apelin receptor for various functions. Hypothalamus, pituitary and ovarian axis is tightly regulated d... To explore the expression of apelin and APJ in HPO axis of mice during estrous cycle, mice were divided into four groups as proestrus, estrus, metestrus and diestrus, and apelin and apelin receptor we... The expression apelin and APJ in the hypothalamus showed elevation during estrous cycle of post-ovulatory phases, metestrus and diestrus. The immunolocalization of apelin and APJ in the anterior pitui... Overall our results showed that apelin system changes along HPO axis during estrous cycle and might have an inhibitory at level of hypothalamus and pituitary and stimulatory at ovarian level....

Usable blastocysts developed from in-vitro-matured metaphase I oocytes in preimplantation genetic testing cycles.

Are blastocysts derived from in-vitro-matured metaphase I (MI) oocytes less likely to produce usable embryos for transfer compared with those derived from in-vivo-matured oocytes in cycles undergoing ... The primary outcome was usable blastocyst rate, which was compared between blastocysts derived from in-vitro-matured MI oocytes after ovarian stimulation and from in-vivo-matured oocytes. Logistic reg... A total of 1810 injected metaphase II (MII) oocytes from 154 PGT cycles involving 154 couples were included in this study. A total of 1577 MII oocytes were in-vivo-matured and 233 were in-vitro-mature... If in-vitro-matured MI oocytes can be fertilized and develop into blastocysts, their ability to provide usable embryos for transfer is similar compared with those developed from in-vivo-matured oocyte...